Skip to content

Vasoactive intestinal peptide (VIP, aviptadil) studies: 420 papers with results

Page 9 of 9

  1. A suppressive effect of dexamethasone (DEX) on adrenocorticotropin (ACTH) response to vasoactive intestinal peptide (VIP) in Cushing's disease: a parallel modulation by DEX of ACTH responses to VIP and corticotropin-releasing hormone.

    Watanobe H · Neuropeptides · 1997

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 3 results

  2. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist.

    Waelbroeck M · Endocrinology · 1985

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 4 results

  3. NANC inhibitory neurotransmission in mouse isolated stomach: involvement of nitric oxide, ATP and vasoactive intestinal polypeptide.

    Mulè F · British journal of pharmacology · 2003

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 2 results

  4. The disodium salt of EDTA inhibits the binding of vasoactive intestinal peptide to macrophage membranes: endodontic implications.

    Segura JJ · Journal of endodontics · 1996

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 2 results

  5. Murine T-lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA.

    Johnson MC · Journal of neuroimmunology · 1996

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 2 results

  6. Purification of [125I]-vasoactive intestinal peptide by reverse-phase HPLC.

    Paul S · Peptides · 1984

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 2 results

  7. Multiplicity of receptors for vasoactive intestinal polypeptide (VIP): differential effects of apamin on binding in brain, uterus and liver.

    Fahrenkrug J · Peptides · 1983

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 2 results

  8. The isolation and chemical characterization of a novel vasoactive intestinal peptide-related peptide from a teleost fish, the cod, Gadus morhua.

    Thwaites DT · Biochimica et biophysica acta · 1989

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 2 results

  9. Purification and structural characterization of vasoactive intestinal polypeptide from the trout and bowfin.

    Wang Y · General and comparative endocrinology · 1995

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 2 results

  10. Human autoantibody to vasoactive intestinal peptide: increased incidence in muscular exercise.

    Paul S · Life sciences · 1988

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 2 results

  11. Vasoactive intestinal peptide receptor expression in chronic periapical lesions.

    Caviedes-Bucheli J · International endodontic journal · 2007

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 2 results

  12. Isolation and amino acid composition of human vasoactive intestinal polypeptide (VIP).

    Carlquist M · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 1982

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 1 result

  13. Spectral and sequence similarity between vasoactive intestinal peptide and the second conserved region of human immunodeficiency virus type 1 envelope glycoprotein (gp120): possible consequences on prevention and therapy of AIDS.

    Veljkovic V · Biochemical and biophysical research communications · 1992

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 1 result

  14. Venous ulcers: improved healing by iontophoretic administration of calcitonin gene-related peptide and vasoactive intestinal polypeptide.

    Gherardini G · Plastic and reconstructive surgery · 1998

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 1 result

  15. Dual bronchodilatory and pulmonary anti-inflammatory activity of RO5024118, a novel agonist at vasoactive intestinal peptide VPAC2 receptors.

    Tannu SA · British journal of pharmacology · 2010

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 1 result

  16. Isolation and amino acid sequences of opossum vasoactive intestinal polypeptide and cholecystokinin octapeptide.

    Eng J · Proceedings of the National Academy of Sciences of the United States of America · 1992

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 1 result

  17. Physicochemical and pharmacological characterization of novel vasoactive intestinal peptide derivatives with improved stability.

    Onoue S · European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2009

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 1 result

  18. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide.

    Tanimoto K · Endocrinology · 1987

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 1 result

  19. Lack of effect of enalaprilat on the action of vasoactive intestinal polypeptide in the human forearm.

    Cockcroft JR · British journal of clinical pharmacology · 1993

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 1 result

  20. Limited proteolysis of the vasoactive intestinal peptide receptor: comparison of its folded structure in the membrane-bound and detergent-solubilized states.

    Provow SA · Regulatory peptides · 1990

    Not a test of Vasoactive intestinal peptide (VIP, aviptadil) alone · 1 result

How PepBank reports evidence